Epstein Secrets

From: Sultan Bin Sulayem To: Jeffrey Epstein <[email protected]> Subject: Fwd: FDA Approved a Potent and Pricey Cholesterol lowering drug today Date: Fri, 24 Jul 2015 20:37:24 +0000 Have

From: Sultan Bin Sulayem To: Jeffrey Epstein <[email protected]> Subject: Fwd: FDA Approv

From: Sultan Bin Sulayem To: Jeffrey Epstein <[email protected]> Subject: Fwd: FD

place statins," says Schliefer, the Regeneron CEO. Most people who have muscle problems from statins do not have those elevated muscle enzymes, says Nissen, the Cleveland Clinic cardiologist, who is conducting a clinical trial Amgen and Pfizer, which is also developing a similar cholesterol drug. He sa

ting: AG Bondi Has a New Probe Into the Handling of 2016 Russian Meddling • Continued Reporting: Judge Will Not Unseal Grand Jury Papers of Maxwell, Epstein's Companion • Former Indianapolis Police Officer Involved in Undercover Cocaine Transaction • South Dakota Highway Patrol Seized Over Two Hundred P

orted that a Manhattan federal judge denied the government's request to unseal grand jury transcripts from the investigation into Ghislaine Maxwell, Jeffrey Epstein's companion. According to the article, the judge stated that unsealing the transcripts would erode confidence in people called to testify before futu

ts from the investigation into Ghislaine Maxwell, Jeffrey Epstein's companion. According to the article, t

ional reporting provided by The 715 Newsroom (08/11, McCarthy). Two Michigan City Council Members Charged With Election Fraud WJBK (Fox-2) (08/11, Nissen) reported that two Hamtramck City Council members, Mohammed Hassan and Muhtasin Sadman, have been charged with multiple felonies, including forging

From: Harry Fisch Sent: Wednesday, April 25, 2018 8:10 PM To: Jeffrey Epstein Subject: FDA advisory committee votes to recommend update to celecoxib safety labeling Family Practice News https://www.mdedge.com/familypractice

Wednesday, April 25, 2018 8:10 PM To: Jeffrey Epstein Subject: FDA advisory committee votes to recomm

h Sent: Wednesday, April 25, 2018 8:10 PM To: Jeffrey Epstein Subject: FDA advisory committee votes t

ascular, GI, or renal=events 28% and 15% more than did patients taking celecoxib. The results of the study could inform clinical strategy, s=id Dr. Nissen, chair of cardiovascular medicine at the Cleveland Clinic in O=io. "For arthritis patients who require NSAIDs to achieve an accept=ble quality of li

From: Sultan Bin Sulayern Sent: 7/24/2015 8:37:24 PM To: Jeffrey Epstein [[email protected]] Subject: Fwd: FDA Approved a Potent and Pricey Cholesterol lowering drug today Importance: — High Have you heard of this co

Sulayern Sent: 7/24/2015 8:37:24 PM To: Jeffrey Epstein [[email protected]] Subject: Fwd: FDA Approve

at patients who have been extremely difficult to treat with high levels of LDL cholesterol,” says Steven HOUSE_OVERSIGHT_025888 --- PAGE BREAK --- Nissen, chairman of cardiology at the Cleveland Clinic. “It’s very promising.” But it will also be very expensive, say Troy Brennan, the chief medical offi

From: jeffrey E. [[email protected]] Sent: 7/24/2015 8:47:39 PM To: Sultan Bin Sulayern Subject: Re: FDA Approved a Potent and Pricey Cholesterol lowering drug t

in the last decade, that will allow us to treat patients who have been extremely difficult to treat with high levels of LDL cholesterol,” says Steven Nissen, chairman of cardiology at the Cleveland Clinic. “It’s very promising.” But it will also be very expensive, say Troy Brennan, the chief medical offi